F A 1 13:00 14:00 O StageIV O O O O O ESD ,2, ,2 1,2 1,
|
|
|
- さみ かくはり
- 5 years ago
- Views:
Transcription
1 11 1 1
2 F A 1 13:00 14:00 O StageIV O O O O O ESD ,2, ,2 1,2 1, O O :00 16:00 S
3 11 1 S S S S S S S S S S E-PASS S P-POSSUM me-pass
4 :20 18:00 R R1-2 double tract R1-3 QOL R R R1-6 U R R R1-9 PGSAS-45 QOL ,2 1,3 1,4 1,5 1,6 1,7 1,8 1,9 1,10 1,
5 11 1 R1-10 QOL PGSAS ,2 1,3 1,4 1,5 1,6 1,7 1,8 1,9 1,10 1, :00 19:00 18
6 :00 12: F B ) :00 14:00 O O O JA O2-4 E-PASS scoring system O2-5 E-PASS scoring system O2-6 Modified Glasgow Prognostic Score O2-7 BMI
7 11 1 O :00 15:00 R R2-2 D2 Reduced-port distal gasterectomy learning curve R2-3 cdst R ,2 1, ,2 1 2 R R2-6 V-Loc R
8 :00 16:30 R R R3-3 Overlap R R R3-6 EndoStitch ENDOCAMELEON , R R R R3-10 Proximal Pouch Roux-Y
9 :30 17:55 2 O O O , O , O3-5 PGSAS ,2 2 1,2 1,2 1, ,2 1 2 O O O O3-9 Hassab 1 5 O DCS
10 11 1 Modified Glasgow prognostic score mgps O O
11 11 2 2
12 :00 8: F A 9:00 10:30 R R4-2 Siewert type R4-3 Siewert type II, III R R R R R4-8 Siewert type R
13 11 2 R R4-11 NAC D1+110,111,19, 20,16a2lat :30 12:00 R R5-2 B-I vs. R-Y R R5-4 QOL Billroth I vs Roux-en Y R5-5 Roux-Y circular stapler - linear stapler R5-6 QOL PGSAS-45 B-I ,11 2,11 3,11 4,11 5,11 6,11 7,11 8,11 9,11 10,
14 11 2 PGSAS-45 R5-7 Roux en Y ,10 2,10 3,10 4,10 5,10 6,10 7,10 8,10 9,10 6, R R5-9 Billroth-IQOL R5-10 Pouch :05 12:55 13:00 15:00 S S , S2-3 PGSAS-45 Billroth-I QOL , NTT 2 29
15 11 2 S S S S2-7 Roux-Y ,3 1,2 1,3 1,3 1,3 1,3 1,3 1, S2-8 pn0 sn lymphatic basin S2-9 QOL PGSAS Liner stapler 15:10 16:00 16:10 17:50 R ,10 2,10 3,10 4,10 5,10 6,10 7,10 8,10 9,
16 11 2 QOL PGSAS-45 R , R6-3 pes NPO R ,11 2,11 3,11 4,11 5,11 6,11 7,11 8,11 9,11 10, R6-5 QOL PGSAS ,10 2,10 3,10 4,10 5,10 6,10 7,10 8,10 9, R6-6 QOL PGSAS ,6 2,6 3,6 4,6 5, R6-7 DAUGS-20 Dysfunction After Upper Gastrointestinal Surgery Alan Lefor
17 11 2 R6-8 QOL pegq NPO R R6-10 In Body
18 11 2 8:30 10:00 4 O4-1 QOL O O O O O O4-7 FDG-PET O4-8 rabeprazole F A O
19 11 2 O O O QOL 10:00 11:10 O5-1 ERAS O5-2 ERAS O5-3 QOL PGSAS ,11 2,11 3,11 4,11 5,11 6,11 7,11 8,11 9,11 10, O5-4 prognostic nutritional index O O
20 O5-7 O O O :20 11: :05 12: :00 14:10 O O6-2 5 O6-3 5 O6-4 LAPG O
21 11 2 O O O O O6-10 J :10 15:20 O7-1 R-Y Aboral pouch CCOG O O7-3 E PASS O O7-5 Roux-en Y
22 11 2 Billroth O7-6 O O7-8 LECS O7-9 L LD7 5 2 O :25 16: :20 17:30 O O O8-3 SMT O8-4 Roux-enY5 37
23 11 2 O8-5 Roux-en-Y 5 O O8-7 Roux-en-Y 1 5 O8-8 Braun O O8-10 Roux-en Y 2 Y O8-11 Roux-en-Y O O8-13 Roux-en-Y 5 38
28kses_program.indd
1-1 4 1 1-2 2 1-3 PTGBD LC 1-4 1-5 2-1 2-2 2-3 Solid-pseudopapillary neoplasm 2 3-1 1 3-2 HALS 3-3 3-4 Siewert type Double Tract 3-5 No.6 4-1 4-2 4-3 1 4-4 QOL Billroth I vs Roux-en Y 4-5 4-6 5-1 5-2 5-3
...1 (1)... 1 (2) ) )... 1 (3)... 1 (4) ) )... 2 (5)... 3 (6)... 3 (7) ) )... 4 (8)... 4 (9)... 4 (10) (1
...1 (1)... 1 (2)... 1 1)... 1 2)... 1 (3)... 1 (4)... 1 1)... 1 2)... 2 (5)... 3 (6)... 3 (7)... 4 1)... 4 2)... 4 (8)... 4 (9)... 4 (10)... 4...5 (1)... 5 1)... 5 2)... 5 (2)... 5 1)... 5 2)... 5 3)...
untitled
1993 2 2.1 2 1 200235 1992 6 7 3 3 84 JA 1990 47.3% 46.5% 1990 31.7% 56.9% 37 6 4 1976 2.2 2.2 1976 1974 1976 1981 1 3.5 1985 60 2005 2006 2006 27 103 522 284 3.5 3.6 2003 109 59.6% 54.1% 31.2% 1970
20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
I? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
1 2 3 4 5 1 1:30 NPO 16 1 19 16 2 17-6 - 10 2008 2010 120 150 IT( ) 60 21 40-7 - - 8-10 ( ) NPO 2 10 16:40-9 - 10 ii NPO NPO ( ) ( ) 11 12 13 14 15 22 26 27 28 29 30 31 32 33 34 m3 m3
44 4 I (1) ( ) (10 15 ) ( 17 ) ( 3 1 ) (2)
(1) I 44 II 45 III 47 IV 52 44 4 I (1) ( ) 1945 8 9 (10 15 ) ( 17 ) ( 3 1 ) (2) 45 II 1 (3) 511 ( 451 1 ) ( ) 365 1 2 512 1 2 365 1 2 363 2 ( ) 3 ( ) ( 451 2 ( 314 1 ) ( 339 1 4 ) 337 2 3 ) 363 (4) 46
i ii i iii iv 1 3 3 10 14 17 17 18 22 23 28 29 31 36 37 39 40 43 48 59 70 75 75 77 90 95 102 107 109 110 118 125 128 130 132 134 48 43 43 51 52 61 61 64 62 124 70 58 3 10 17 29 78 82 85 102 95 109 iii
JA2008
A1 1 10 vs 3 2 1 3 2 0 3 2 10 2 0 0 2 1 0 3 A2 3 11 vs 0 4 4 0 0 0 0 0 3 6 0 1 4 x 11 A3 5 4 vs 5 6 5 1 0 0 3 0 4 6 0 0 1 0 4 5 A4 7 11 vs 2 8 8 2 0 0 0 0 2 7 2 7 0 2 x 11 A5 9 5 vs 3 10 9 4 0 1 0 0 5
１
10 1113 14 1516 1719 20 21 22 2324 25 2627 i 2829 30 31 32 33 3437 38 3941 42 4344 4547 48 4950 5152 53 5455 ii 56 5758 59 6061 iii 1 2 3 4 5 6 7 8 9 10 PFI 30 20 10 PFI 11 12 13 14 15 10 11 16 (1) 17
001 No.3/12 1 1 2 3 4 5 6 4 8 13 27 33 39 001 No.3/12 4 001 No.3/12 5 001 No.3/12 6 001 No.3/12 7 001 8 No.3/12 001 No.3/12 9 001 10 No.3/12 001 No.3/12 11 Index 1 2 3 14 18 21 001 No.3/12 14 001 No.3/12
Professor Emeritus of Surgery, The University of Iowa College of Medicine Ken Kimura
51 3 2015 5 351 52 1 5 28 1 8 55 9 00 9 00 10 30 1 Keynote Lecture RS1-1 RS1-2 RS1-3S OCIAD2 DNA I RS1-4 Kif26A KO RS1-5 RS1-6S TLR-4 IL-4 DEC205 RS1-7S PGE-MUM 10 30 11 20 1 OS1-1 MAPK in vitro OS1-2
, ,
41 42 73 121 121 10 122 11 122 12 131 13 131 15 10 133 16 11 133 17 12 136 18 13 141 19 14 141 20 15 146 21 16 149 22 17 149 23 174 18 24 73 19 241,301 25 20 242,301 (1) 26 21 331 27 22 241,341 28 23 242,341
NPO 1 2 3 77 4 5 6 7 21 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67
20110124-02-01
100 13 13 148 4 60 8 21 18 3 2 19 2 23 3 22 22 9 23 10 1 2 18 3 3 60.0 31.12 33.3 24.5 23.1 22.7 29 201714 22 13.310 32 12.137 11.2 65 22 20.532 27.437 28.7 18 1 46.31 81.6 20.9 23.821.4 19.0 34.9 28.9
勘定科目別経理セミナー
16 8 21 2 15-1 (1) (2) (3) (4) (5) 3 (6) (7) (1) (2) (3) (1) (2) (3) 4 (4) (1) (2) (3) 5 8/1 8/30 9/20 20 (1) (2) (3) (4) 6 (1) (2) (3) (4) 7 (1) (2) (3) (4) (5) (6) 8 (1) (2) 50% (1) (2) 9 (3) (1) (2)
untitled
420 40 41 100 18 6 18 61 17 1 20 29 10 12 2.0 17 4.3 12 17 400-10 65 40,438 17 24.2 19.9 15 35 60 17 60 17 1700 17 65 2 17 23 58,000 28 58,900 1 23 2.77 / 28 2.63 / 7 17 15 15 11,769 3 60 17 45,618 59.36
- 82 -
- 82 - 1 2 3 4 5 6-83 - 7 3,000 100 8 9 10 11 4559 59 24 51 61 51-84 - 5373-85 - 3,000 100 3,000 12 100-86 - 1,000 44 5462-87 - 3,000 23 24 10,000 23 8,000 24 2,000 22 2,000 23 22 2,000 8,000 3,000 22
Microsoft Word - 文書4
5 8 NPO http://plaza.rakuten.co.jp/dassen/ http://www.youtube.com/watch?v=rcdkhqunyte 20 10 10 10 20 10 20 10 20 20 2 1 '93.5 http://youtu.be/gwrfcglitxk 7 1 13 5000 20 1000 60 550 30 20 1 9 14 3 5 50
大崎市耐震改修促進計画（案）
1 1 2 2 4 2520 5661 3 1 4 2 12 11 15 11 12 20 1 11 5 3 19781933 6 7 4 8 9 1 10 7 11 50 90 3 12 56 1 13 14 15 2 56,041 30,528 54,572 10,991 27 27 27 16 17 18 19 1 20 21 22 2 3 4 23 5 24 6 25 1-26 2 3 4
1 2 (1) (2) (3) 10 (4) 10 (5) 12 3 (1) 13 (2) 13 (3) 14 4 (1) 14 (2) 15 (3) 15 (4) 16 (5) 16 1 2009 24 1,440 360 2 (1) 1,800 (2) 23 4 1 102 169 73 96 13 5 1 178 69 1 NPO 4 1 2 40 35 4 3 23 4 1 1 443 622-0844
01_表紙_修
0% 20% 40% 60% 80% 100% H7 H12 H17 H22 19.1% 17.1% 15.5% 14.4% 65.1% 64.5% 63.9% 62.2% 15.8% 18.4% 20.6% 23.4% H27 H27 H27 13.7% 13.0% 12.6% 59.2% 57.4% 60.7% 27.1% 29.6% 26.6% 15 1564 65 3.50 3.00 2.50
EX-word_Library_JA
JA 2 3 4 5 14 7 1 2 6 3 1 2 7 3 8 27 1 2 3 1 2 3 9 1 2 3 1 2 3 10 12 13 14 11 1 12 1 2 13 1 2 3 25 14 1 2 3 25 15 1 2 3 25 16 1 2 3 25 17 1 2 3 25 18 1 2 3 4 25 19 1 2 3 4 25 20 1 2 21 3 4 25 22 1 2 3
『こみの株式会社』の実践
2003 . JA JA A JA 811 2005/8/11 1003 452 10 960 28 2005/8/11 1003 452 6 120 29 2005/8/11 2003 151 10 420 33 2005/8/11 2003 211 3 180 31 2005/8/11 2003 211 3 150 32 827 400 5 80 221 2005/6/25 900 3 300
15 7 26 1,276 3,800 1 16 15 1 2 3 4 2
1 15 7 26 1,276 3,800 1 16 15 1 2 3 4 2 JA 3 4 2 1 3 2001 1981 6 10% 10 30% 1 2 JA JA 2 4 JA 2 1 2 1 2 1 2 1 2 1 2 7 5 1 1 1 3 1 6 1 1 2 2 1 7 2 3 3 53 1 2000 30 8 250 53 435 20 35 3 1 8 2 4 3 2 2 232
324.pdf
50 50 10 30 11 26 12 27 14 16 27 18 20 21 22 22 22 22 23 24 24 1 No.324 JA 2 85 69 20 12 81 18 12 22 93 10 31 3 50 50 30 30 50 22 27 27 10 16 14 52 10 62 15 64 25 24 50 4 25 23 27 5 10 11 25 6 11 49 10
EV200R I II III 1 2 3 4 5 6 7 8 9 10 1 2 3 11 4 5 12 6 13 1 2 14 3 4 15 5 16 1 2 17 3 18 4 5 19 6 20 21 22 123 456 123 456 23 1 2 24 3 4 25 5 3 26 4 5 6 27 7 8 9 28 29 30 31 32 1 2 33 3 4 34 1 35 2 1
（個別のテーマ） 薬剤に関連した医療事故
- 67 - III - 68 - - 69 - III - 70 - - 71 - III - 72 - - 73 - III - 74 - - 75 - III - 76 - - 77 - III - 78 - - 79 - III - 80 - - 81 - III - 82 - - 83 - III - 84 - - 85 - - 86 - III - 87 - III - 88 - - 89
（個別のテーマ） 放射線検査に関連した医療事故
- 131 - III - 132 - - 133 - III - 134 - - 135 - III - 136 - - 137 - III - 138 - - 139 - III - 140 - - 141 - III - 142 - - 143 - III - 144 - - 145 - III - 146 - - 147 - III - 148 - - 149 - III - 150 - -
訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書
1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....
23 15961615 1659 1657 14 1701 1711 1715 11 15 22 15 35 18 22 35 23 17 17 106 1.25 21 27 12 17 420,845 23 32 58.7 32 17 11.4 71.3 17.3 32 13.3 66.4 20.3 17 10,657 k 23 20 12 17 23 17 490,708 420,845 23
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ( ) 24 25 26 27 28 29 30 ( ) ( ) ( ) 31 32 ( ) ( ) 33 34 35 36 37 38 39 40 41 42 43 44 ) i ii i ii 45 46 47 2 48 49 50 51 52 53 54 55 56 57 58
untitled
i ii (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3) (2) (3) (1) (2) (3) (1) (1) (1) (1) (2) (1) (3) (1) (2) (1) (3) (1) (1) (1) (2) (1) (3) (1) (1) (2) (1) (3)
平成１８年度「商品先物取引に関する実態調査」報告書
... 1.... 5-1.... 6-2.... 9-3.... 10-4.... 12-5.... 13-6.... 15-7.... 16-8.... 17-9.... 20-10.... 22-11.... 24-12.... 27-13... 29-14.... 32-15... 37-16.... 39-17.... 41-18... 43-19... 45.... 49-1... 50-2...
521 1 I. 1) 18 20087510.4 20552.56565 200920156 20102015 17 20092015665 5003007520 6465006500 65500 200520153.32.3 樋 100 6 20 20 20086522.17510.4 20552.56575 15641.31 2) 18 2005 UNWorld Population Prospects:
i
14 i ii iii iv v vi 14 13 86 13 12 28 14 16 14 15 31 (1) 13 12 28 20 (2) (3) 2 (4) (5) 14 14 50 48 3 11 11 22 14 15 10 14 20 21 20 (1) 14 (2) 14 4 (3) (4) (5) 12 12 (6) 14 15 5 6 7 8 9 10 7
第１部 一般的コメント
(( 2000 11 24 2003 12 31 3122 94 2332 508 26 a () () i ii iii iv (i) (ii) (i) (ii) (iii) (iv) (a) (b)(c)(d) a) / (i) (ii) (iii) (iv) 1996 7 1996 12
第１章 国民年金における無年金
1 2 3 4 ILO ILO 5 i ii 6 7 8 9 10 ( ) 3 2 ( ) 3 2 2 2 11 20 60 12 1 2 3 4 5 6 7 8 9 10 11 12 13 13 14 15 16 17 14 15 8 16 2003 1 17 18 iii 19 iv 20 21 22 23 24 25 ,,, 26 27 28 29 30 (1) (2) (3) 31 1 20
本文_P _セッション.indd
19 5 11 13:30 14 : 10 1 TAPP 5 11 11:30 12 : 20 1 Bogros space of Bogros Retzius space of Retzius 5 10 12:40 13 : 10 1 TEPP 5 10 13:10 13 : 40 1 IL - 1-1 Laparoscopic Hernioplasty development of technique,
技能継承に関するアンケートの結果概要
I 1 1 1 1 1 1 2 1 3 1 II 2 1 2 2 2 3 2007 2 4 3 III 4 1 4 4 5 6 2 7 7 8 9 3 10 _10 11 _12 _13 _14 15 4 2007 16 2007 16 17 2007 18 5 19 19 I 2007 1 2005 6 21 8 3 3000 2 292 292 9.7 3 100 1 II 1 86 2 OJT
untitled
2000 2005 2 4 2011 4 19 2000 5 2009 2 2000 2010 5 10 6 180 38.3 17.5 30 9.0 0 0.7 1085 15 1 20 2000 3,800 5 1 800 5 1878 111920 91943 18 5 200592 1946 21 3 1956 31 3 1983 2000 1983 2 30 1987126 2000 1
2708 日本 臨 床 外 科 学 会雑 誌 Table 1 Laboratory data 66巻 on admission Fig. 2: Gastrointestinal the left hollow hollow was endoscopy the was the afferent was
2708 日本 臨 床 外 科 学 会雑 誌 Table 1 Laboratory data 66巻 on admission Fig. 2: Gastrointestinal the left hollow hollow was endoscopy the was the afferent was the transverse Fig. 3: Abdominal demonstrated efferent
.g...N...|.[.g25
20039 NPO NPO 20039 NPO 3 2006 91 83 84 1 NPO 1 85 495,800 105 2 200412 2004 1,550 841 200530 20042005 13.4NPO 5.2 393 44334 151 2005:11 1 n=841 2004 86 2005 1 2 7 75.0 4 2 n=17 2005 75.0 37.5 25.0 18.8
077-089/fiñfi¡‰ž
49 2006 77 89 Nito Miyako 1402 81 1455 57 49 2006 1 49 2006 10 ii iii iii iii 11 12 13 14 ii 15 16 17 18 49 2006 19 20 21 22 23 24 49 2006 25 49 2006 26 27 28 29 1435 1511 30 31 1475 1550 32 49 2006 1739
provider_020524_2.PDF
1 1 1 2 2 3 (1) 3 (2) 4 (3) 6 7 7 (1) 8 (2) 21 26 27 27 27 28 31 32 32 36 1 1 2 2 (1) 3 3 4 45 (2) 6 7 5 (3) 6 7 8 (1) ii iii iv 8 * 9 10 11 9 12 10 13 14 15 11 16 17 12 13 18 19 20 (2) 14 21 22 23 24
「産業上利用することができる発明」の審査の運用指針（案）
1 1.... 2 1.1... 2 2.... 4 2.1... 4 3.... 6 4.... 6 1 1 29 1 29 1 1 1. 2 1 1.1 (1) (2) (3) 1 (4) 2 4 1 2 2 3 4 31 12 5 7 2.2 (5) ( a ) ( b ) 1 3 2 ( c ) (6) 2. 2.1 2.1 (1) 4 ( i ) ( ii ) ( iii ) ( iv)
i
i ii iii iv v vi vii viii ix x xi ( ) 854.3 700.9 10 200 3,126.9 162.3 100.6 18.3 26.5 5.6/s ( ) ( ) 1949 8 12 () () ア イ ウ ) ) () () () () BC () () (
1 2 3 4 1 3 4 2 5 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 21 24 25 26 27 28 29 30 31 32 33 34 9 35 36 14 9 14 15 37 38 39 35 1 519 4 NPO 40 41 9 10 4 (9 Or10 ) PR 3 21 21 42 2 10 43 44 15
i ii iii iv v vi vii ( ー ー ) ( ) ( ) ( ) ( ) ー ( ) ( ) ー ー ( ) ( ) ( ) ( ) ( ) 13 202 24122783 3622316 (1) (2) (3) (4) 2483 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) 11 11 2483 13